127 related articles for article (PubMed ID: 4042986)
1. Disturbed prolactin responses to dopamine-related substances in patients with acromegaly and hyperprolactinemia.
Sekiya K; Karashima T; Ikuyama S; Muta K; Kato K; Ibayashi H
Endocrinol Jpn; 1985 Apr; 32(2):207-14. PubMed ID: 4042986
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic neurotransmitter function in experimentally induced hyperprolactinemia.
Peñalva A; Novelli A; Parenti M; Locatelli V; Müller EE; Cocchi D
Brain Res; 1984 Dec; 324(2):233-41. PubMed ID: 6099203
[TBL] [Abstract][Full Text] [Related]
3. Dynamic testing of prolactin and growth hormone secretion in patients with neuroendocrine disorders.
Müller EE; Cavagnini F; Martinez-Campos A; Maraschini C; Giovannini P; Novelli A; De Leo V
Acta Endocrinol (Copenh); 1984 Oct; 107(2):155-63. PubMed ID: 6437104
[TBL] [Abstract][Full Text] [Related]
4. Tests of prolactin secretion in the diagnosis of hyperprolactinemic states: nomifensine and domperidone.
Massara F; Genazzani AR; Camanni F; De Leo V; Molinatti GM; Müller EE
Fertil Steril; 1981 Feb; 35(2):149-54. PubMed ID: 7202740
[TBL] [Abstract][Full Text] [Related]
5. Plasma pituitary hormone responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases.
Demura R; Suda T; Wakabayashi I; Yoshimura M; Jibiki K; Odagiri E; Demura H; Shizume K
J Clin Endocrinol Metab; 1981 Feb; 52(2):263-6. PubMed ID: 7462391
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of hypothalamic hyperprolactinemia.
Ferrari C; Rampini P; Benco R; Caldara R; Scarduelli C; Crosignani PG
J Clin Endocrinol Metab; 1982 Nov; 55(5):897-901. PubMed ID: 6811605
[TBL] [Abstract][Full Text] [Related]
7. Persistence of a defective tuberoinfundibular dopaminergic function in rats after long-term removal of oestrogen treatment. An in vivo study.
Cocchi D; Peñalva A; Torpia R; Rossi GL; Müller EE
Acta Endocrinol (Copenh); 1985 Jul; 109(3):309-14. PubMed ID: 4024849
[TBL] [Abstract][Full Text] [Related]
8. Central inhibitory action of TRH on prolactin secretion in the rat.
Ohta H; Kato Y; Matsushita N; Shimatsu A; Kabayama Y; Imura H
Proc Soc Exp Biol Med; 1985 May; 179(1):9-12. PubMed ID: 3921974
[TBL] [Abstract][Full Text] [Related]
9. Impaired prolactin responsiveness to dopamine antagonists in acromegaly.
Camanni F; Massara F; Santià M; Molinatti GM; Müller EE
Metabolism; 1982 Nov; 31(11):1090-5. PubMed ID: 7132736
[TBL] [Abstract][Full Text] [Related]
10. Plasma LH, FSH and TSH responses to the synthetic enkephalin analog (FK 33-824) in normal subjects and patients with pituitary diseases.
Demura R; Suda T; Wakabayashi I; Ono M; Jibiki K; Odagiri E; Demura H; Shizume K
Tohoku J Exp Med; 1982 Jul; 137(3):283-7. PubMed ID: 6810504
[TBL] [Abstract][Full Text] [Related]
11. Prolactin response to the dopamine antagonists sulpiride and domperidone. Further evidence for pituitary dopamine deficiency in hyperprolactinemic disorders of different etiology.
Ferrari C; Scarduelli C; Rampini P; Brambilla G; Benco R; Pistolesi E; Paracchi A; Mattei A; Boghen M; Crosignani PG
Gynecol Obstet Invest; 1983; 16(5):299-306. PubMed ID: 6642291
[TBL] [Abstract][Full Text] [Related]
12. Prolactin-releasing effect of domperidone in normoprolactinemic and hyperprolactinemic subjects.
Camanni F; Genazzani AR; Massara F; La Rosa R; Cocchi D; Müller EE
Neuroendocrinology; 1980; 30(1):2-6. PubMed ID: 7354887
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
14. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
[TBL] [Abstract][Full Text] [Related]
15. Exaggerated circadian variation in basal thyrotropin (TSH) and in the dopaminergic inhibition of TSH release in pathological hyperprolactinemia: evidence against a hypothalamic dopaminergic defect.
Rodriguez-Arnao MD; Peters JR; Foord SM; Dieguez C; Edwards C; Gomez-Pan A; Hall R; Newcombe RG; Scanlon MF
J Clin Endocrinol Metab; 1983 Nov; 57(5):975-80. PubMed ID: 6619271
[TBL] [Abstract][Full Text] [Related]
16. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia.
Dallabonzana D; Spelta B; Botalla L; Oppizzi G; Silvestrini F; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1982 Jun; 54(6):1125-8. PubMed ID: 7076795
[TBL] [Abstract][Full Text] [Related]
17. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
Valensi P; Combes ME; Perret G; Attali JR
J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
[TBL] [Abstract][Full Text] [Related]
18. Diminished prolactin reserve in acromegaly.
Spitz IM; Barzilai D; Luboshitzky R
Metabolism; 1980 Sep; 29(9):880-4. PubMed ID: 6774202
[TBL] [Abstract][Full Text] [Related]
19. Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.
Ferrari C; Romussi M; Benco R; Rampini P; Mailland F
Acta Endocrinol (Copenh); 1983 May; 103(1):1-6. PubMed ID: 6407250
[No Abstract] [Full Text] [Related]
20. Nomifensine: diagnostic test in hyperprolactinemic states.
Müller EE; Genazzani AR; Murru S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]